Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Genenta Science
company
About
Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- €13.20M
- Industries
- Biotechnology,Clinical Trials,Genetics,Health Care
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors. The company is based in Milan, Italy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€13.20M
Genenta Science has raised a total of
€13.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 11, 2019 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 11, 2019 | Series C | €13.20M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Genenta Science is funded by 1 investors.
Qianzhang Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
